Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation

NCT01251952 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Drug unavailable

Conditions

Multiple Myeloma

Interventions

DRUG: Denileukin Diftitox (Ontak)

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]